Evolution of clinical nature, treatment and survival of locally recurrent rectal cancer: Comparative analysis of two national cross-sectional cohorts

In the Netherlands, use of neoadjuvant radiotherapy for rectal cancer declined after guideline revision in 2014. This decline is thought to affect the clinical nature and treatability of locally recurrent rectal cancer (LRRC). Therefore, this study compared two national cross-sectional cohorts before and after the guideline revision with the aim to determine the changes in treatment and survival of LRRC patients over time.

Source: European Journal of Cancer - March 20, 2024 Category: Cancer & Oncology Authors: E.G.M. van Geffen, J.M.A. Langhout, S.J.A. Hazen, T.C. Sluckin, S. van Dieren, G.L. Beets, R.G.H. Beets-Tan, W.A.A. Borstlap, J.W.A. Burger, K. Horsthuis, M.P.W. Intven, A.G.J. Aalbers, K. Havenga, A.W.K.S. Marinelli, J. Melenhorst, J. Nederend, H.M.U. Pe Tags: Original Research Source Type: research